Skip to content

Clinical trials

Phase 3 Tachycardia, Ventricular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tachycardia, Ventricular Phase: Phase 3 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20102
20111
20132
20182
20192
20216
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated7
Unknown status3
Recruiting2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Milestone Pharmaceuticals Inc.4
National Heart, Lung, and Blood Institute (NHLBI)3
Ottawa Heart Institute Research Corporation2
AstraZeneca1
Centro Medico Teknon1
Corxel Pharmaceuticals1
Fondazione IRCCS Policlinico San Matteo di Pavia1
Helse Stavanger HF1
Institute for Clinical and Experimental Medicine1
Medical University of Graz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tachycardia, Ventricular25
Ventricular Fibrillation8
Arrhythmias, Cardiac6
Death, Sudden, Cardiac6
Heart Diseases5
Cardiovascular Diseases4
Atrial Fibrillation3
Myocardial Ischemia3
Heart Failure2
Tachycardia, Atrioventricular Nodal Reentry2

Trials

Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.